Protalix BioTherapeutics PLX
NYSE PLX
$2.57 +0.00 (+0.00%)
As of: Oct 22, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Protalix BioTherapeutics' Return on Capital Employed [ROCE] was 31.08% in Q2 2026, up 15.29 percentage points from 15.79% a year earlier and up 0.61 percentage points from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Protalix BioTherapeutics came in at -10.71%, down 18.06 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a four-year change of +43.68 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was 7.35% in FY2024 (-35.21 pp), 42.55% in FY2023 (+82.85 pp), -40.29% in FY2022 (+14.09 pp) and -54.39% in FY2021.
  • The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in four of the last eight quarters, with an average year-over-year change of +3.32 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2023 (a gain of 97.00 percentage points); the worst was Q2 2024 (a drop of 67.90 percentage points).
  • Per Business Quant data, PLX's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 30.47% (Q1 2026), -9.86% (Q4 2025) and 10.90% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 17.52%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 17.92%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.28%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 16.76%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 11.86%
10 Protalix BioTherapeutics 204.37 Mn 52.98 Mn 12.13 Mn 31.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.08%
Mar 31, 2026 30.47%
Dec 31, 2025 -9.86%
Sep 30, 2025 10.90%
Jun 30, 2025 15.79%
Mar 31, 2025 9.38%
Dec 31, 2024 9.36%
Sep 30, 2024 -17.02%
Jun 30, 2024 -45.20%
Mar 31, 2024 24.96%
Dec 31, 2023 25.85%
Sep 30, 2023 30.43%
Jun 30, 2023 22.70%
Mar 31, 2023 -45.87%
Dec 31, 2022 -54.64%
Sep 30, 2022 -66.57%
Jun 30, 2022 -44.66%
Mar 31, 2022 -52.18%
Dec 31, 2021 -45.07%
Sep 30, 2021 -22.45%
API Access

Protalix BioTherapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PLX&period=max&api_key=YOUR_API_KEY